INT215630

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0.26
Pain Relevance 0.76

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

pigmentation (Fig4) extracellular space (Npy) extracellular region (Npy)
Golgi apparatus (Fig4) endoplasmic reticulum (Fig4)
Anatomy Link Frequency
CPA 2
Fig4 (Rattus norvegicus)
Npy (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Neuropeptide 10 100.00 Very High Very High Very High
adenocard 184 98.48 Very High Very High Very High
agonist 54 97.52 Very High Very High Very High
antagonist 36 94.28 High High
depression 6 66.32 Quite High
Pyramidal cell 14 52.52 Quite High
Glutamate 28 5.00 Very Low Very Low Very Low
Hippocampus 28 5.00 Very Low Very Low Very Low
gABA 26 5.00 Very Low Very Low Very Low
Central nervous system 20 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Depression 6 66.32 Quite High
Hypoxia 16 5.00 Very Low Very Low Very Low
Disease 12 5.00 Very Low Very Low Very Low
Neurological Disease 10 5.00 Very Low Very Low Very Low
Bordatella Infection 4 5.00 Very Low Very Low Very Low
Convulsion 4 5.00 Very Low Very Low Very Low
Drug Induced Neurotoxicity 4 5.00 Very Low Very Low Very Low
Ataxia 4 5.00 Very Low Very Low Very Low
Parkinson's Disease 2 5.00 Very Low Very Low Very Low
Necrosis 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Fig2Effect of neuropeptide Y (NPY) on the PSPs alone and in combination with the selective A1R agonist N6-cyclopentyladenosine (CPA) after preincubation with the selective A1R antagonist 1,3-dipropyl-8-cyclopentylxantine (DPCPX) (Sichardt et al., unpublished results).
Fig Regulation (2Effect) of NPY in CPA associated with antagonist, agonist and neuropeptide
1) Confidence 0.01 Published 2007 Journal Purinergic Signal Section Body Doc Link PMC2072922 Disease Relevance 0.13 Pain Relevance 0.38
Fig2Effect of neuropeptide Y (NPY) on the PSPs alone and in combination with the selective A1R agonist N6-cyclopentyladenosine (CPA) after preincubation with the selective A1R antagonist 1,3-dipropyl-8-cyclopentylxantine (DPCPX) (Sichardt et al., unpublished results).
Fig Regulation (2Effect) of neuropeptide Y in CPA associated with antagonist, agonist and neuropeptide
2) Confidence 0.01 Published 2007 Journal Purinergic Signal Section Body Doc Link PMC2072922 Disease Relevance 0.13 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox